Irregular expression of hyaluronan and its CD44 receptor is associated with metastatic phenotype in laryngeal squamous cell carcinoma

Virchows Archiv

Volumn 434, Issue 1, 1999, Pages 37-44

  Hirvikoski, Pasi ^a,b   Tammi, Raija ^b   Kumpulainen, Eero ^a   Virtaniemi, Jukka ^a   Parkkinen, Jyrki J ^a,b   Tammi, Markku ^b   Johansson, Risto ^a   Ågren, Ulla ^b   Karhunen, Jouko ^c   Kosma, Veli Matti ^a,b  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c Ctrl Finland Health Care District ^*  (Finland)

Author keywords

Adhesion; CD44 receptor; Hyaluronic acid; Laryngeal neoplasms; Prognosis

Indexed keywords

HERMES ANTIGEN; HYALURONIC ACID; LYMPHOCYTE ANTIGEN RECEPTOR; MONOCLONAL ANTIBODY; PROTEOGLYCAN;

ADULT; AGED; ARTICLE; CANCER STAGING; CELL DIFFERENTIATION; CONTROLLED STUDY; DISEASE COURSE; EPITHELIUM CELL; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; MITOSIS INDEX; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; STAINING; STATISTICAL ANALYSIS; T LYMPHOCYTE; TISSUE DISTRIBUTION;

ANTIGENS, CD44; CARCINOMA, SQUAMOUS CELL; HUMANS; HYALURONIC ACID; LARYNGEAL NEOPLASMS; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; PHENOTYPE; SURVIVAL RATE;

EID: 0032965715     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004280050302     Document Type: Article

References (42)

1. 1. Ågren U, Tammi R, Tammi M (1997) Reactive oxygen species contribute to epidermal hyaluronan catabolism in human skin organ culture. Free Radic Biol Med 23:996-1001
2. 2. Alho A, Underbill C (1989) The hyaluronate receptor is preferentially expressed on proliferating epithelial cells. J Cell Biol 108:1557-1565
3. 3. Auvinen P, Parkkinen J, Johansson R, Ågren U, Tammi R, Eskelinen M, Kosma V-M (1997) Expression of hyaluronan in benign and malignant breast lesions. Int J Cancer [Pred Oncol] 74:477-481
4. 4. Bartolazzi A, Peach R, Aruffo A, Stamenkovic I (1994) Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development. J Exp Med 180:53-66
5. 5. Bazil V, Strominger JL (1994) Metalloprotease and serine protease are involved in cleavage of CD43, CD44, and GD16 from stimulated human granulocytes. Induction of cleavage of L-selectin via CD16. J Immunol 152:1314-1322
6. 6. Castella E, Ariza A, Fernandez Vasalo A, Roca X, Ojanguren I (1996) Expression of CD44H and CD44v3 in normal oesophagus, Barrett mucosa and oesophageal carcinoma. J Clin Pathol 49:489-492
7. 7. Fujita N, Yaegashi N, Ide Y, Sato S, Nakamura M, Ishiwata I, Yajima A (1994) Expression of CD44 in normal human versus tumor endometrial tissues: possible implication of reduced expression of CD44 in lymph - vascular space involvement of cancer cells. Cancer Res 54:3922-3928
8. 8. Haapasalo H, Collan Y, Pesonen E (1989) Volume corrected mitotic index (M/V index) - the standard of mitotic activity in neoplasms. Pathol Res Pract 185:551-554
9. 9. Herold-Mende C, Seiter S, Born AI, Patzelt E, Schupp M, Zoller J, Bosch FX, Zoller M (1996) Expression of CD44 splice variants in squamous epithelia and squamous cell carcinomas of the head and neck. J Pathol (Lond) 179:66-73
10. 10. Hirvikoski P, Kumpulainen E, Virtaniemi J, Johansson R, Haapasalo H, Marin S, Halonen P, Helin H, Raitiola H, Pukander J, Kellokumpu-Lehtinen P, Kosma V-M (1997) p53 expression and cell proliferation as prognostic factors in laryngeal squamous cell carcinoma. J Clin Oncol 15:3111-3120
11. 11. Hudson DL, Sleeman J, Watt FM (1995) CD44 is the major peanut lectin-binding glycoprotein of human epidermal keratinocytes and plays a role in intercellular adhesion. J Cell Sci 108:1959-1970
12. 12. Hudson DL, Speight PM, Watt FM (1996) Altered expression of CD44 isoforms in squamous-cell carcinomas and cell lines derived from them. Int J Cancer 66:457-463
13. 13. Jalkanen S, Bargatze R, de los Toyos J, Butcher E (1987) Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95 kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal or synovial endothelial cells. J Cell Biol 105:983-990
14. 14. Kaya G, Rodriguez I, Jorcano J, Vassalli P, Stamenkovic I (1997) Selective suppression of CD44 in keratinocytes of mice bearing an antisense CD44 transgene driven by a tissue-spesific promoter disrupts hyaluronate metabolism in the skin and impairs keratinocyte proliferation. Genes Dev 11:996-1007
15. 15. Kimata K, Honma Y, Okayama M, Kayoko O, Hozumi M, Suzuki S (1983) Increased synthesis of hyaluronic acid by mouse mammary carcinoma cell variants with high metastatic potential. Cancer Res 43:1347-1354
16. 16. Knudson W, Biswas C, Li X-Q, Nemec RE, Toole PB (1989) The role and regulation of tumour-associated hyaluronan. Ciba Found Symp 143:150-169
17. 17. Lesley J, English N, Perschi A, Gregoroff J, Hyman R (1995) Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation. J Exp Med 182:431-437
18. 18. Liu D, Pearlman E, Diaconu E, Guo K, Mori H, Haqqi T, Markowitz S, Willson J, Sy M-S (1996) Expression of hyaluronidase by tumor cells induces angiogenesis in vivo. Proc Natl Acad Sci USA 93:7832-7837
19. 19. Muller D, Wolf C, Abecassis J, Millon R, Engelman A, Bronner G, Rouyer N, Rio M-C, Eber M, Methlin G, Chambon P, Basset P (1993) Increased stromelysin 3 gene expression is associated with increased local invasiveness in head and neck cell carcinomas. Cancer Res 53:165-169
20. 20. Okada A, Bellocq J-P, Ruoyer N, Chenard M-P, Rio MC, Chambon P, Basset P (1995) Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc Natl Acad Sci USA 92:2730-2734
21. 21. Prehm P (1984) Hyaluronate is synthesized at plasma membranes. Biochem J 220:597-600
22. 22. Ristamäki R, Joensuu H, Jalkanen S (1996) Does soluble CD44 reflect the clinical behavior of human cancer? Curr Top Microbiol Immunol 213:155-166
23. 23. Roye GD, Myers RB, Brown D, Poczatek R, Beenken SW, Grizzle WE (1996) CD44 expression in dysplastic epithelium and squamous-cell carcinoma of the esophagus. Int J Cancer 69:254-258
24. 24. Rudzki Z, Jothy S (1997) CD44 and the adhesion of neoplastic cells. J Clin Pathol [Mol Pathol] 50:57-71
25. 25. Salmi M, Grön-Virta K, Sointu P, Grenman R, Kalimo H, Jalkanen S (1993) Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular origin. J Cell Biol 122:431-442
26. 26. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell JI (1992) Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 89:12160-12164
27. 27. Seelentag WK, Gunthert U, Saremaslani P, Futo E, Pfaltz M, Heitz PU, Roth J (1996) CD44 standard and variant isoform expression in human epidermal skin tumors is not correlated with tumor aggressiveness but down-regulated during proliferation and tumor de-differentiation. Int J Cancer 69:218-224
28. 28. Seiter S, Tilgen W, Herrmann K, Schadendorf D, Patzelt E, Moller P, Zoller M (1996) Expression of CD44 splice variants in human skin and epidermal tumours. Virchows Arch 428:141-149
29. 29. Shanmugaratnam K, Sobin LH (1991) Histological typing of tumours of the upper respiratory tract and ear. Springer, Berlin Heidelberg New York
30. 30. Sobin LH, Wittekind (1997) UICC International Union Against Cancer: TNM classification of malignant tumors. Wiley-Liss, New York
31. 31. Soukka T, Salmi M, Joensuu H, Häkkinen L, Sointu P, Koulu L, Kalimo K, Klemi P, Grenman R, Jalkanen S (1997) Regulation of CD44v6-containing isoforms during proliferation of normal and malignant epithelial cells. Cancer Res 57:2281-2289
32. 32. Stamenkovic I, Aruffo A, Amiot M, Seed B (1991) The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J 10:343-348
33. 3H]thymidine incorporations and staining of hyaluronan on mitotic keratinocytes. Exp Cell Res 195:524-527
34. 34. Tammi R, Ripellino JA, Margoulis RU, Tammi M (1988) Localization of epidermal hyaluronic acid using the hyaluronate binding region of cartilage proteoglycan as a spesific probe. J Invest Dermatol 90:412-414
35. 35. Tammi R, Tammi M, Häkkinen L, Larjava H (1990) Histochemical localization of hyaluronate in human oral epithelium using a specific hyaluronate-binding probe. Arch Oral Biol 35:219-224
36. 36. Tammi R, Ågren UM, Tuhkanen AL, Tammi M (1994) Hyaluronan metabolism in skin. Prog Histochem Cytochem 29:1-81
37. 37. Toole B (1982) Glycosaminoglycans in morphogenesis. In: Hay E (ed) Cell biology of the extracellular matrix. Plenum Press, New York
38. 38. Toole BP (1991) Proteoglycans and hyaluronan in morphogenesis and differentiation. In: Hay ED (ed) Cell biology of the extracellular matrix. Plenum Press, New York
39. 39. Tuhkanen A-L, Tammi M, Tammi R (1997) CD44 substituted with heparan sulfate and endo-beta-galactosidase-sensitive oligosaccharides: a major proteoglycan in adult human epidermis. J Invest Dermatol 109:213-218
40. 40. Van Muijen GN, Danen EH, Veerkamp JH, Ruiter DJ, Lesley J, van den Heuvel LP (1995) Glycoconjugate profile and CD44 expression in human melanoma cell lines with different metastatic capacity. Int J Cancer 61:241-248
41. 41. Wang C, Tammi M, Guo H, Tammi R (1996) Hyaluronan distribution in the normal epithelium of esophagus, stomach, and colon and their cancers. Am J Pathol 148:1861-1869
42. 42. Wang C, Tammi M, Tammi R (1992) Distribution of hyaluronan and its CD44 receptor in the epithelia of human skin appendages. Histochemistry 98:105-112